2011Xiandai yufang yixueRequires access

EFFECTS OF FASUDIL ON S-100B PROTEIN AND HIGH-SENSITIVITY C-REACTIVE PROTEIN IN ACUTE CEREBRAL INFARCTION PATIENTS

Chang Li

Open publisher page 0 citations

Abstract

[Objective]To study effects of fasudil on S-100B protein and high-sensitivity C-reactive protein in acute cerebral infarction patients.[Methods]A randomized double-blind study was designed to value effects of fasudil on acute cerebral infarction,with routine therapy as placebo-control group.One hundred and six patients were chosen from Jun 2009 to Dec 2010,which were divided into two groups:fasudil group(56 cases)and control group(50 cases).Serum levels of S100B protein,serum levels of hs-CRP,improvement of neurological function were observed.[Results]There were better clinical outcomes in the two groups,P﹤0.01.There was a significant difference between two groups.In fasudil group,serum levels of S100B protein,serum levels of hs-CRP,improvement of neurological function were markedly different compared with those in placebo-control group(P﹤0.05).[Conclusion]Fasudil can significantly decrease the level of S100B protein and hs-CRP,and improve the neurological function of cerebral infarction patients.

About this research paper

What this paper is about

[Objective]To study effects of fasudil on S-100B protein and high-sensitivity C-reactive protein in acute cerebral infarction patients.[Methods]A randomized double-blind study was designed to value effects of fasudil on acute cerebral infarction,with routine therapy as placebo-control group.One hundred and six patients were chosen from Jun 2009 to Dec 2010,which were divided into two groups:fasudil group(56 cases)and control group(50 cases).Serum levels of S100B protein,serum levels of hs-CRP,improvement of neurological function were observed.[Results]There were better clinical outcomes in the two groups,P﹤0.01.There was a significant difference between two groups.In fasudil group,serum levels of S100B protein,serum levels of hs-CRP,improvement of neurological function were markedly different compared with those in placebo-control group(P﹤0.05).[Conclusion]Fasudil can significantly decrease the level of S100B protein and hs-CRP,and improve the neurological function of cerebral infarction patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective]To study effects of fasudil on S-100B protein and high-sensitivity C-reactive protein in acute cerebral infarction patients.[Methods]A randomized double-blind study was designed to value effects of fasudil on acute cerebral infarction,with routine therapy as placebo-control group.One hundred and six patients were chosen from Jun 2009 to Dec 2010,which were divided into two groups:fasudil group(56 cases)and control group(50 cases).Serum levels of S100B protein,serum levels of hs-CRP,improvement of neurological function were observed.[Results]There were better clinical outcomes in the two groups,P﹤0.01.There was a significant difference between two groups.In fasudil group,serum levels of S100B protein,serum levels of hs-CRP,improvement of neurological function were markedly different compared with those in placebo-control group(P﹤0.05).[Conclusion]Fasudil can significantly decrease the level of S100B protein and hs-CRP,and improve the neurological function of cerebral infarction patients.

Key concepts: Fasudil, Medicine, C-reactive protein, Cerebral infarction, Placebo, Gastroenterology, Internal medicine, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
EFFECTS OF FASUDIL ON S-100B PROTEIN AND HIGH-SENSITIVITY C-REACTIVE PROTEIN IN ACUTE CEREBRAL INFARCTION PATIENTS — Research Paper | ScholarLens